Why the study?
Does molecular autopsy identify pathogenic mutations in young people and infants with autopsy-negative sudden unexplained death?
Population
Young people and infants with autopsy-negative sudden unexplained death or sudden infant death syndrome
Design
Review
Authors
Loading...
May support family screening after SUD/SIDS; leaves open prospective validation before routine adoption.
Does molecular autopsy identify pathogenic mutations in young people and infants with autopsy-negative sudden unexplained death?
Molecular autopsy is a valuable tool for identifying pathogenic cardiac channel mutations in cases of autopsy-negative sudden unexplained death, guiding pre-emptive strategies for surviving family members.
Tester et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: